Biktarvy, formally known as bictegravir, represents a potent single-tablet treatment for treating HIV infection. This formula integrates three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the HIV's ability to copy within the body, significantly reducing the viral load. For many individu